Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 1741 AL 1755

Bridging the global Parkinson's divide: Technology as a structural solution for equitable and brain health-integrated care

Bhidayasiri R, Schneider RB, Maetzler W, Espay AJ, Lim TT, Phoumindr A, Kumar H, Pilotto A, Bloem BR.

J Parkinsons Dis. 2026 Jul 7:1877718X261466810. doi: 10.1177/1877718X261466810. Online ahead of print.

Sex-specific gut microbiota and metabolite signatures in Parkinson's disease: implications for personalized therapeutics

Sharma SA, Patri M.

Metab Brain Dis. 2026 Jul 7;41(1):158. doi: 10.1007/s11011-026-01924-7.

Transthyretin at the crossroads of neurodegeneration: a silent guardian in Parkinson's disease

Dipa P, Aran KR.

Metab Brain Dis. 2026 Jul 7;41(1):157. doi: 10.1007/s11011-026-01907-8.

β-sitosterol and next-generation neuroprotection for multi-target strategies and the gut-brain axis in neurodegenerative diseases

Sivalingam AM.

J Steroid Biochem Mol Biol. 2026 Jul 7;264:107080. doi: 10.1016/j.jsbmb.2026.107080. Online ahead of print.

Ageing-driven gastrointestinal variability in Parkinson's disease: implications for oral levodopa pharmacokinetics and formulation design

Madny MA, Yadav KS.

Eur J Pharm Biopharm. 2026 Sep;226:115179. doi: 10.1016/j.ejpb.2026.115179. Epub 2026 Jul 9.

Biological sex differences in neurodegenerative diseases in Africa: a scoping review of evidence and research gaps

Njohjam MN, Ngoule MO, Niakam TF.

BMC Neurol. 2026 Jul 7. doi: 10.1186/s12883-026-05123-w. Online ahead of print.

GLP-1 receptor agonists in neurological diseases: mechanisms and therapeutic prospects from metabolism to neuroprotection

Yang M, Liang Z.

Front Immunol. 2026 Jun 23;17:1839620. doi: 10.3389/fimmu.2026.1839620. eCollection 2026.

Enhanced Gait Variability Index in Neurological and Geriatric Rehabilitation: A Scoping Review

Wang M, Karakkattil P.

NeuroRehabilitation. 2026 Sep;59(2):200-217. doi: 10.1177/10538135261465012. Epub 2026 Jul 8.

Phase Separation Drives Pathological Aggregation in Neurodegenerative Diseases: A 15-Year Bibliometric Landscape (2009-2024)

Zhang C, Chen S, Zhao H, Wang Y, Zhou L, Fan H, Sun Y.

Ann N Y Acad Sci. 2026 Jul;1561(1):e70311. doi: 10.1111/nyas.70311.

Phase separation and protein aggregation in neurodegenerative diseases

de La Seiglière H, Letourneur Æ, Ichas F, De Giorgi F.

Biophys Chem. 2026 Nov;338:107678. doi: 10.1016/j.bpc.2026.107678. Epub 2026 Jul 4.

Machine learning-based detection of Parkinson's disease from facial expressions, hand movements, speech, and gait with general-purpose equipment: a systematic review

Moshkova AA, Novikova AO, Polguev MI, Kubinskaya DD, Ershova MV, Ivanova EO, Fedotova EY, Yurchenko SO, Illarioshkin SN, Samorodov AV, Piradov MA.

Int J Med Inform. 2026 Nov 1;220:106587. doi: 10.1016/j.ijmedinf.2026.106587. Epub 2026 Jul 5.

The autophagy-senescence-inflammasome axis: A novel triad in neurodegenerative diseases?

Ellappan S, Kujur PP, Mondal AC.

Ageing Res Rev. 2026 Oct;121:103248. doi: 10.1016/j.arr.2026.103248. Epub 2026 Jul 8.

Association of long-term outdoor air pollution exposure with incidence of Parkinson's disease, multiple sclerosis and motor neuron diseases: a systematic review and meta-analysis

Tien-Smith AZ, Absar S, Rogowski CB, Phillips V, Andersen ZJ, Bredell C, Fung KW, Hong L, Szybka M, Woodcock J, Brayne C, Khreis H, Navaratnam AMD.

Environ Int. 2026 Aug;214:110377. doi: 10.1016/j.envint.2026.110377. Epub 2026 Jun 20.

Understanding the genetic imperfections of Lewy body dementia

Watkins MM, Xhafkollari G, Zhao N, Ross OA.

Mol Neurodegener. 2026 Jul 8. doi: 10.1186/s13024-026-00961-1. Online ahead of print.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias